Form D · Biotechnology
Pasithea Therapeutics Corp.
Miami Beach, FL · CIK 0001841330
Offering snapshot reported Dec 7, 2021 · SEC filing
- Reported sold
- $30.4M Offering amount: $30.4M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 29, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2021 | Initial | $30,380,000 | No comparison | 21 | SEC filing |
| Mar 19, 2021 | Initial | $1,208,926 | No comparison | 30 | SEC filing |
| Jan 29, 2021 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.73M
- Finders' fees
- $0
- Form D file number
- 021-423899
The securities were issued in an offering of 8,680,000 shares and 8,680,000 warrants issued as part of a PIPE transaction, for $3.50 per share and accompanying warrant.
EF Hutton also received a cash fee equal to 1.0% of the gross proceeds raised by the Company in the Offering for non-accountable expenses, and $70,000 for accountable expenses.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| EF Hutton, division of Benchmark Investments, LLC | 103792 |
Source: Form D, filed Dec 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Israel Maxx Abramowitz | Director, Executive |
| Craig Auringer | Director, Executive |
| Yassine Bendiabdallah | Director, Executive |
| Simon Dumesnil | Director |
| Stanley M. Gloss | Executive |
| Emer Leahy | Director |
| Tiago Reis Marques | Director |
| Tiago Andre Dos Reis Marques | Director, Executive |
| Lawrence Steinman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1111 Lincoln Road Suite 500
Miami Beach, FL, 33139
Miami Beach, FL, 33139